Evolus Inc Stock Return On Asset
| EOLS Stock | USD 9.93 0.25 2.46% |
Fundamental analysis of Evolus allows traders to better anticipate movements in Evolus' stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Evolus Inc Company Return On Asset Analysis
Evolus' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Evolus Return On Asset | -0.0936 |
Most of Evolus' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evolus Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Evolus Inc has a Return On Asset of -0.0936. This is 98.93% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is 33.14% lower than that of the firm.
Evolus Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evolus' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Evolus could also be used in its relative valuation, which is a method of valuing Evolus by comparing valuation metrics of similar companies.Evolus is currently under evaluation in return on asset category among its peers.
Evolus Fundamentals
| Return On Equity | -9.49 | ||||
| Return On Asset | -0.0936 | ||||
| Profit Margin | (0.20) % | ||||
| Operating Margin | (0.19) % | ||||
| Current Valuation | 718.67 M | ||||
| Shares Outstanding | 64.48 M | ||||
| Shares Owned By Insiders | 5.46 % | ||||
| Shares Owned By Institutions | 85.33 % | ||||
| Number Of Shares Shorted | 9.67 M | ||||
| Price To Earning | (5.55) X | ||||
| Price To Book | 53.71 X | ||||
| Price To Sales | 2.40 X | ||||
| Revenue | 266.27 M | ||||
| Gross Profit | 188.46 M | ||||
| EBITDA | (25 M) | ||||
| Net Income | (50.42 M) | ||||
| Cash And Equivalents | 84.48 M | ||||
| Cash Per Share | 1.51 X | ||||
| Total Debt | 129.98 M | ||||
| Debt To Equity | 1.59 % | ||||
| Current Ratio | 2.60 X | ||||
| Book Value Per Share | (0.10) X | ||||
| Cash Flow From Operations | (18 M) | ||||
| Short Ratio | 8.41 X | ||||
| Earnings Per Share | (0.89) X | ||||
| Price To Earnings To Growth | (0.52) X | ||||
| Target Price | 23.57 | ||||
| Number Of Employees | 372 | ||||
| Beta | 1.0 | ||||
| Market Capitalization | 656.36 M | ||||
| Total Asset | 232.57 M | ||||
| Retained Earnings | (609.4 M) | ||||
| Working Capital | 88.38 M | ||||
| Current Asset | 27.24 M | ||||
| Current Liabilities | 76.8 M | ||||
| Net Asset | 232.57 M |
About Evolus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Evolus Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evolus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evolus Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Evolus Stock Analysis
When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.